|Articles|November 1, 2002

The American Journal of Managed Care

  • November 2002
  • Volume 8
  • Issue 11

State Regulation of Private Health Insurance: Prescription Drug Benefits, Experimental Treatments, and Consumer Protection

Download PDF: State Regulation of Private Health Insurance: Prescription Drug Benefits, Experimental Treatments, and Consumer Protection

Articles in this issue

over 23 years ago

Pill Splitting

over 23 years ago

Do Disease Management Programs for Patients With Coronary Heart Disease Make a Difference? Experiences of Nine Practices

over 23 years ago

Use of a Disease Severity Index for Evaluation of Healthcare Costs and Management of Comorbidities of Patients With Diabetes Mellitus

over 23 years ago

Understanding Changes in Primary Care Clinicians' Satisfaction From Depression Care Activities During Adoption of Selective Serotonin Reuptake Inhibitors

over 23 years ago

Antibiotic Resistance: The Iowa Experience

over 23 years ago

When Do Developing Countries Adopt Managed Care Policies and Technologies? Part I: Policies, Experience, and a Framework of Preconditions

over 23 years ago

Therapeutic Options for the Management of Type 2 Diabetes Mellitus

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text